anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
Hair loss is a pressing concern that affects one's quality of life and even self-esteem, which is caused by heredity through genetic disposition and disparity of hormones. In order to deal with hair loss, consumers are seeking for remedies that are readily available in the market. However, these readily available remedies contain synthetic medications that impart adverse effects in the long run. With this, the interest for organic and natural remedies, such as Halal products, and with minimal environmental effect is on the rise. The formulation of bar shampoo using Halal ingredients addresses the hair loss problem that is faced by many, by imparting beneficial effects such as hair growth-promoting properties. The present utility model relates to a standardized process of producing a bar shampoo with hair growth promoting properties using Halal ingredients, through mixing of the halal ingredients to produce the desired bar shampoo.
An infusion of 0.25 mg.kg-1.h-1 is started at T0 (incision) with an infusion pump and is kept at the same rate until the surgical team starts closing the deep layers of the abdominal incision. Consumption of the infusion pump is noted at T0 (incision) and at each hour during the surgery until the infusion is discontinued.
The utility model discloses a medicine subsides relates to the plaster field for optimize the structure of medicine subsides. The medicinal patch comprises a substrate, a medicinal base layer and a medicinal sealing layer. The substrate is configured as a sheet. The medicine base layer is attached to the substrate; the medicine base layer is provided with a plurality of storage tanks, and mutual independence between each storage tank, every storage tank all is constructed for placing the medicament. The medicine sealing layer covers the medicine base layer and is positioned on one side of the medicine base layer away from the substrate; the drug seal is configured to cover and seal the receiving slot. The medicine patch provided by the technical scheme has the advantages that the plurality of mutually independent accommodating grooves are formed, the shapes and the dosages of the medicines in the accommodating grooves can be freely set, and the accommodating grooves are distributed in a dispersing way and distributed in a multi-point way, so that the adverse effects caused by long-term interaction of certain medicines can be reduced, the medicine patch can have more components, the defect of single medicine effect of the medicines is overcome, and the structure of the medicine patch is optimized.
Cystic lesions of the kidney, thyroid, and liver are commonly treated with ethanol injections into the cyst cavity. The contact with ethanol results in rapid elimination of epithelial cells lining cyst cavities with few complications or pain. The majority of cysts become smaller and some are completely eliminated Depending on the type of cyst and tissue, some cysts can be completely ablated with ethanol. Although malignant masses arising from the pancreas have been safely injected with ethanol, there are no reports of injection of pancreatic cystadenomas. The ability to ablate cystadenomas of the pancreas would provide the first non-surgical treatment for these pre-malignant lesions of the pancreas.

Over the past two years we have conducted a pilot study of EUS-guided ethanol lavage of pancreatic cysts (2001-P-000358/5). 18 patients have undergone the procedure without evidence of pancreatitis, pain, or infection following the procedure. Initially, low concentrations of ethanol were used (5%) and over the course of the study, the concentration of the ethanol used for lavage has been increased to 60%. Although the patients have not undergone careful follow-up evaluations, it appears that at least 4 of the patients have had resolution of the cyst.

This is a prospective, randomized, blinded, controlled trial of ethanol ablation in 50 patients with a pancreatic cystadenoma. Patients with a pancreatic cyst (1-5cm in diameter) capable of safely undergoing endoscopy with conscious sedation will be candidates. Exclusion criteria include: coagulopathy (INR\>1.5, PTT\>100, platelets of\< 50k), active infection of the cyst or unstable cardio-pulmonary disease (active angina, home O2, or pulmonary edema) will be excluded.

At the time of diagnostic cyst aspiration, the patient will be randomized to either saline lavage or ethanol (70%) lavage. During the exam, the cyst will be imaged with ultrasound, measured and aspirated. The cyst contents will be evaluated with cytologic evaluation, CEA, and amylase. After cyst aspiration, the cyst will be lavaged with either saline or ethanol for 5 minutes. At completion of the lavage, the cyst contents will be evacuated. The patient will be provided the results of the cyst fluid analysis and may elect to undergo surgical resection or additional lavage treatments. At the time of resection, the cyst and surrounding pancreas will be resected for histologic analysis. The degree of epithelial ablation will be determined with histologic sectioning and the cysts lavaged with ethanol will be compared to those cysts lavaged with saline. If the patient chooses not to have a surgical resection, the patient may return for a follow-up EUS exam at two additional monthly intervals with cyst aspiration and additional ethanol lavage. Those patients receiving saline during the initial treatment session will be crossed-over to ethanol.
This is an 8-week mindfulness-based group intervention delivered via telehealth. It consists of mindfulness and meditative practice, didactics, inquiry, discussion and weekly therapeutic exercises and assignments (i.e., homework).
The invention comprises the preparation of compounds of general formula <FORM:1002649/C3/1> where R is a chelating compound which is a polymeric glycose of which each glycose unit has from 3 to 6 carbon atoms which comprises the steps of intermittently mixing phenyl butazone and the chelation compound (e.g. gum guar, pectose, psylium seed, algin, dextran) in a polar solvent which is then removed.  The description also refers to reaction by mixing in organic media generally, and to the products as being hydrogen bonded.ALSO:Pharmaceutical compositions contain compounds of general formula <FORM:1002649/A5-A6/1> where R is a chelating compound which is a polymeric glycose of which each glycose unit has from 3 to 6 carbon atoms (e.g. gum guar, pectose, psylium seed, algin, dextran), with carriers. Forms mentioned are tablets, capsules, suppositories and parenteral preparations.  The compounds are analgesic, antipyretic and antiflammatory agents.
Pancreatic stone protein (PSP) is an acute-phase reactant mainly produced in response to stress. Its diagnostic and prognostic accuracy for several types of infection has been studied in several clinical settings. The aim of the current review was to assess all studies examining a possible connection of pancreatic stone protein levels with the severity and possible complications of patients diagnosed with infection. We performed a systematic search in PubMed, Scopus, the Cochrane Library and Clinicaltrials.gov to identify original clinical studies assessing the role of pancreatic stone protein in the diagnosis and prognosis of infectious diseases. We identified 22 eligible studies. Ten of them provided diagnostic aspects, ten studies provided prognostic aspects, and another two studies provided both diagnostic and prognostic information. The majority of the studies were performed in an intensive care unit (ICU) setting, five studies were on patients who visited the emergency department (ED), and three studies were on burn-injury patients. According to the literature, pancreatic stone protein has been utilized in patients with different sites of infection, including pneumonia, soft tissue infections, intra-abdominal infections, urinary tract infections, and sepsis. In conclusion, PSP appears to be a useful point-of-care biomarker for the ED and ICU due to its ability to recognize bacterial infections and sepsis early. Further studies are required to examine PSP's kinetics and utility in specific populations and conditions.
Dyads will receive mailed print education materials regarding healthy lifestyle (nutrition and physical activity) disseminated by ACS and NCI. They will also receive 12 weekly phone calls to assess post-treatment related symptoms.
With the allied invasion, the southern half of Iran became the scene of a large presence of British and American occupation forces. The negative consequences of the styling of foreign elements during all the years of war and even afterward affected these areas in various dimensions of their health. The negative consequences of the occupation of southern Iran, the health and healthcare system of this part of Iran suffered problems in various forms of shortage of medicines, equipment, and treatment staff, especially the spread of various infectious and communicable diseases. The article aims to examine the effects of World War II on the southern, southwestern, and eastern regions of Iran from 1939 to 1945 and its consequences in the spread of infectious diseases in these regions. The research with an analytical-historical method relies on the library method and is based on the study of the data of unpublished documents from the archives of the National Archives and Library Organization, medical and economic social publications, and various local and public newspapers of Iran during this period. The study of documents and publications shows that due to Allied restrictive policies and successive waves of famine and widespread malnutrition, epidemic diseases, and drug monopoly, these areas experienced a period of severe decline in public health and spread of various infectious diseases.
High blood pressure contributes to the racial disparities in death rates between minority patients and whites. Understanding the factors underlying racial disparities in high blood pressure-related outcomes is a major focus of Healthy People 2010. Several factors including access to care, patient preferences and lower socioeconomic status have been used to explain the differences seen in timely and effective delivery of preventive care between minority patients and whites. However, when these factors are controlled for, health disparities still exist. Recently, the Institute of Medicine identified interpersonal processes within the patient-provider relationship as a potential reason for the health disparities between minority and white patients. Specifically, providers' communication, including the ability to listen, collaborate, and be empathetic during the medical encounter has emerged as an important dimension of care that differs by race. Despite the increasing evidence that racial differences in patient-provider communication affects patient care, many of these studies have examined issues related to processes of care such as patient satisfaction with little attention to intermediate outcomes such as medication adherence. Further, studies that have used audio-taped analysis to examine racial differences in patient-provider communication are limited by one-dimensional coding systems that lack the ability to capture the mutual influence the patient and provider have on one another during the interaction. Thus, the potential pathways through which patient-provider communication contribute to high blood pressure-related disparities in minority patients compared to whites is not clearly understood. This proposed two-phase, mixed-methods research study, provides a unique opportunity to address these gaps by clarifying the effect of patient's race on patient-provider communication and medication adherence among 120 hypertensive African American and white patients receiving care in primary care practices. Specifically, findings from a qualitative analysis of patient-provider communication (Phase 1) will inform the development of a conceptual model that will be used to quantitatively evaluate the relationship between patient's race, patient-provider communication and medication adherence (Phase 2).
In this condition, participants are not exposed to any sound. The Ultrasound dummy source is placed close to the participant's bed, exactly like in the Infrasound - verum condition (1-2 meters). The Ultrasound dummy source looks exactly like the active ultrasound source, but produces no sound at all. Participants are told that this source emits sound for 8 constant hours during their night sleep.
COVID-19 disease has caused one of the largest pandemics in world history. Two and a half years after the WHO declared a pandemic status for COVID-19, it is known that about 10-20% of Covid-19 patients fail to recover their initial health status and report persistent symptoms over time. This group of people suffer from what has been defined by the WHO as post-COVID-19 condition. Among this group of patients, the most common symptoms observed are fatigue, shortness of breath and cognitive dysfunction, as well as psychological sequelae. Among the latter, the group of Emotional Disorders ( EDs), a nomenclature that groups anxiety disorders, depressive and related disorders, are those most commonly reported by people with post-COVID-19 condition, with alarmingly high rates of persistent psychological distress (36%), anxiety disorders (22%), depression (21%), post-traumatic stress disorder (20%) and sleep disorders (35%). Therefore, it is necessary to apply intervention programs for the treatment of psychological sequelae derived from post-COVID-19 condition, as well as emotional demands and needs in this population highly affected by the COVID-19 pandemic.

The overall objective of this trial is to study the efficacy and acceptability of the "Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders" (UP) in the treatment of emotional symptomatology and/or ED in a sample of patients with post-COVID-19 condition. The investigators hypothesize that a structured psychological intervention focused on treating emotional dysregulation (the UP), a factor shared by the group of EDs, will generate an improvement in the emotional state of this group of patients.
A system for facilitating the process of hiring nurses and other medical workers utilizes a Mobile App and a Website that executes medical job transactions. It processes patient data hence reduces the likelihood of medical errors. The system works in conjunction with a scheduling system to schedule workers. It processes registration of medical workers for short term jobs and registers employers to post jobs. Posted job listings are displayed for workers. Once a worker applies, an alert is sent to the employer that posted the job. The employer views the worker's photo after hiring them and the worker is alerted on their mobile device and email. Employers pay electronically through credit card or bank account and workers are paid electronically. The system which identifies patients by patient identification number, location, sex and age verifies patient data by scanning QR Code or Barcode on patient's arm or bed.
PURPOSE:To obtain the subject granules of extremely stable persistence in the releasing rate of the active ingredient invariant, causing no environmental air pollution during its production and capable of producing using a simple equipment by dispersing a medical active ingredient in hardened cottonseed oil. CONSTITUTION:The objective granules can be obtained by dispersing a medical active ingredient in hardened cottonseed oil. The melting point of the cottonseed oil is pref. ca.40 to 70 deg.C (esp. ca.50 to 70 deg.C). The active ingredient is e.g. theophylline, caffeine, phenyl propanolamine hydrochloride, idebenone, ketoprofen, cyclandelate. The rate of said active ingredient to be formulated in the cottonseed oil is, depending on the kind of the ingredient to be applied and other additive(s), which is normally ca.0.0005 to 75 (pref. 0.01 to 50)wt.%.
A dental caries preventive and sensitive teeth toothpaste; for twice daily self-applied topical use, followed by rinsing. Helps reduce the painful sensitivity of the teeth to cold, heat, acids, sweets or contact in adult patients and children 12 years of age and older. It is well established that 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators. 1-4 PreviDent® 5000 Sensitive brand of 1.1% sodium fluoride toothpaste with 5% potassium nitrate in a squeeze bottle is easily applied onto a toothbrush. This prescription toothpaste should be used twice daily in place of your regular toothpaste unless otherwise instructed by your dental professional. May be used in areas where drinking water is fluoridated since topical fluoride cannot produce fluorosis. (See WARNINGS for exception.)
BACKGROUND AND PURPOSE: Mean pulmonary artery pressure (mPAP) is a key index for chronic thromboembolic pulmonary hypertension (CTEPH). Using machine learning, we attempted to construct an accurate prediction model for mPAP in patients with CTEPH.
METHODS: A total of 136 patients diagnosed with CTEPH were included, for whom mPAP was measured. The following patient data were used as explanatory variables in the model: basic patient information (age and sex), blood tests (brain natriuretic peptide (BNP)), echocardiography (tricuspid valve pressure gradient (TRPG)), and chest radiography (cardiothoracic ratio (CTR), right second arc ratio, and presence of avascular area). Seven machine learning methods including linear regression were used for the multivariable prediction models. Additionally, prediction models were constructed using the AutoML software. Among the 136 patients, 2/3 and 1/3 were used as training and validation sets, respectively. The average of R squared was obtained from 10 different data splittings of the training and validation sets.
RESULTS: The optimal machine learning model was linear regression (averaged R squared, 0.360). The optimal combination of explanatory variables with linear regression was age, BNP level, TRPG level, and CTR (averaged R squared, 0.388). The R squared of the optimal multivariable linear regression model was higher than that of the univariable linear regression model with only TRPG.
CONCLUSION: We constructed a more accurate prediction model for mPAP in patients with CTEPH than a model of TRPG only. The prediction performance of our model was improved by selecting the optimal machine learning method and combination of explanatory variables.
Recurrent aphthous stomatitis leads to ulcers that cause severe pain, which is a substantial burden on patients. Equisetum arvense extract (EA) is a crude drug that promotes wound healing of mucous membranes caused by perineal incision during childbirth and alleviates pain. Here, we elucidated the effects of EA on wound healing and pain in a stomatitis hamster model. After stomatitis induction, two different EA doses were continuously applied to the wound area through the intramucosal injection of acetic acid into the cheek pouch (stomatitis/100*EA group and stomatitis/EA group). The body weight and wound area were measured over time, and histological evaluation was performed after stomatitis induction. The wound area was harvested 10 h after stomatitis induction, and gene expression associated with pain and inflammation was analyzed using qPCR. The dorsal root ganglia of the rat spinal cord were isolated, dispersed, and cultured to examine the inhibitory effect of EA on the K+-evoked release of neurotransmitter substance P. In the stomatitis/100*EA group, a significant reduction in wound size was observed compared with the stomatitis/physiological saline (PS) group, and the weight gain rate was considerably higher. The stomatitis/EA group revealed similar histological changes in the wound and wound size as the stomatitis/PS group; however, the weight gain rate was considerably higher on day 7. The stomatitis/EA group suppressed the expression of inflammatory cytokine mRNA, such as Tnf-α and Il-6, and Cox-2 mRNA in the wound area compared with the stomatitis/PS group. EA treatment reduced the upregulated substance P release from the dorsal root ganglia following high-concentration K+ stimulation. EA alleviates pain in a stomatitis model by suppressing inflammatory cytokine expression in the wound area and substance P release from primary sensory neurons. Therefore, using oral care products containing EA is expected to suppress stomatitis pain.
PURPOSE:To obtain a permanent waving agent, capable of suppressing damage of hair and scalp and having excellent waving effects by blending a high- molecular weight silicone in at least either of the first and second agent of a cold two-bath type permanent waving agent. CONSTITUTION:A permanent waving agent obtained by blending 0.01-5wt.%, preferably 0.05-1wt.% linear silicone expressed by the formula (R1 is methyl or partially phenyl; R2 is methyl or OH; n is 2000-30000) or a silicone resin having or capable of forming a three-dimensional network structure in at least either of the first agent consisting essentially of a reducing agent (e.g. thioglycolic acid or cysteine) and the second agent consisting essentially of an oxidizing agent (e.g. potassium bromate or aqueous hydrogen peroxide). The high-molecular weight silicone is preferably predissolved in a low-boiling oil (e.g. cyclic or linear silicone or 3-30C isoparaffin) and blended therewith. The low-boiling oil is blended in an amount within the range of preferably 0.05-25wt.%.
Although diabetes mellitus negatively affects post-ischaemic stroke injury and recovery, its impact on intracerebral haemorrhage (ICH) remains uncertain. This study aimed to investigate the effect of experimental diabetes (ED) on ICH-induced injury and neurological impairment. Sprague-Dawley rats were induced with ED 2 weeks before ICH induction. Animals were randomly assigned to four groups: 1)Healthy; 2)ICH; 3)ED; 4)ED-ICH. ICH and ED-ICH groups showed similar functional assessment. The ED-ICH group exhibited significantly lower haemorrhage volume compared with the ICH group, except at 1 mo. The oedema/ICH volume ratio and cistern displacement ratio were significantly higher in the ED-ICH group. Vascular markers revealed greater expression of α-SMA in the ED groups (ED and ED-ICH) compared with ICH. Conversely, the ICH groups (ED-ICH and ICH) exhibited higher levels of VEGF compared to the healthy and ED groups. An assessment of myelin tract integrity showed an increase in fractional anisotropy in the ED and ED-ICH groups compared with ICH. The ED group showed higher cryomyelin expression than the ED-ICH and ICH groups. Additionally, the ED groups (ED and ED-ICH) displayed higher expression of MOG and Olig-2 than ICH. As for inflammation, MCP-1 levels were significantly lower in the ED-ICH groups compared with the ICH group. Notably, ED did not aggravate the neurological outcome; however, it results in greater ICH-related brain oedema, greater brain structure displacement and lower haemorrhage volume. ED influences the cerebral vascularisation with an increase in vascular thickness, limits the inflammatory response and attenuates the deleterious effect of ICH on white matter integrity.